HLA-DQB1 Antibodies

Santa Cruz Biotechnology offers a broad range of HLA-DQB1 monoclonal antibodies for immunology and related research fields. HLA-DQB1 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-DQB1 is a critical component of the major histocompatibility complex (MHC) class II molecules, playing a vital role in the immune response by presenting peptides to CD4+ T cells. HLA-DQB1 enables recognition of foreign antigens and has significant implications in autoimmune diseases and transplant rejection. Understanding HLA-DQB1 function and regulation advances therapeutic strategies in immunotherapy and transplantation. Researchers studying immune system responses can explore antigen presentation mechanisms through detailed analysis of HLA-DQB1 expression patterns. Current investigations focus on how HLA-DQB1 variations influence susceptibility to various autoimmune conditions. Examining HLA-DQB1 interactions with other immune components provides valuable information about immune response regulation. Santa Cruz Biotechnology monoclonal antibodies for HLA-DQB1 support researchers worldwide in advancing our understanding of immune system function and disease mechanisms.